NuSkin Enterprises, Inc. (NUS)

Price$5.28

Value ScoreA

Growth ScoreF

Momentum ScoreD

Favorite Metrics

Price vs S&P 500 (26W)-57.58%

Price vs S&P 500 (4W)-28.55%

VGM Score41.18

Market Capitalization$270.47M

P/E Ratio (Annual)1.69x

Indicated Dividend Yield (Annual)4.29%

All Metrics

P/CF (Annual)3.37x

Book Value / Share (Quarterly)$16.34

P/TBV (Annual)0.61x

Indicated Dividend (Annual)$0.24

Revenue Growth (3Y)-12.62%

Cash Flow / Share (Quarterly)$0.86

Payout Ratio (TTM)21.47%

Price vs S&P 500 (YTD)-53.17%

Gross Margin (TTM)69.31%

Net Profit Margin (TTM)3.78%

EPS (TTM)$1.09

10-Day Avg Trading Volume0.69M

EPS Excl Extra (TTM)$1.09

Revenue Growth (5Y)-10.47%

EPS (Annual)$3.18

Dividend / Share (Annual)$0.24

ROI (Annual)15.47%

Gross Margin (Annual)69.45%

Net Profit Margin (5Y Avg)2.59%

Cash / Share (Quarterly)$4.12

P/E Basic Excl Extra (TTM)4.96x

Revenue Growth QoQ (YoY)-12.04%

EPS Growth (5Y)-2.56%

P/E Normalized (Annual)1.69x

ROA (Last FY)11.40%

Revenue Growth TTM (YoY)-14.17%

EBITD / Share (TTM)$2.60

ROE (5Y Avg)5.25%

Operating Margin (TTM)5.53%

Cash Flow / Share (Annual)$0.95

P/B Ratio0.34x

P/B Ratio (Quarterly)0.45x

Net Income / Employee (Annual)$57,200

EV / Revenue (TTM)0.20x

Net Interest Coverage (TTM)5.67x

ROA (TTM)3.86%

EPS Growth QoQ (YoY)-98.26%

EV / EBITDA (TTM)2.27x

EPS Incl Extra (Annual)$3.18

Current Ratio (Annual)2.08x

Quick Ratio (Quarterly)0.95x

3-Month Avg Trading Volume0.57M

52-Week Price Return-32.77%

EV / Free Cash Flow (Annual)6.42x

P/E Incl Extra (TTM)4.96x

Revenue / Employee (TTM)$514,700

Tangible BV / Share (Quarterly)$15.53

P/S Ratio (Annual)0.18x

Asset Turnover (Annual)1.06x

52-Week High$14.62

Operating Margin (5Y Avg)4.73%

EPS Excl Extra (Annual)$3.18

CapEx CAGR (5Y)-11.68%

Tangible BV CAGR (5Y)-1.07%

26-Week Price Return-44.00%

Quick Ratio (Annual)1.14x

13-Week Price Return-30.69%

Total Debt / Equity (Annual)0.29x

Current Ratio (Quarterly)2.03x

Enterprise Value$295.40M

Revenue / Share Growth (5Y)-9.60%

Asset Turnover (TTM)1.02x

Book Value / Share Growth (5Y)-1.00%

Revenue / Employee (Annual)$530,400

Inventory Turnover (Annual)2.46x

Pretax Margin (Annual)13.21%

Cash / Share (Annual)$5.02

3-Month Return Std Dev36.97%

Gross Margin (5Y Avg)70.64%

Net Income / Employee (TTM)$19,500

EBITDA CAGR (5Y)-2.37%

EBITDA Interim CAGR (5Y)-27.41%

ROE (Last FY)19.90%

Net Interest Coverage (Annual)5.30x

EPS Basic Excl Extra (Annual)$3.18

P/FCF (TTM)4.57x

Receivables Turnover (TTM)28.37x

EV / Free Cash Flow (TTM)7.11x

Total Debt / Equity (Quarterly)0.28x

EPS Incl Extra (TTM)$1.09

Receivables Turnover (Annual)32.88x

ROI (TTM)5.30%

Dividend Growth Rate (5Y)-30.34%

P/S Ratio (TTM)0.19x

Pretax Margin (5Y Avg)3.41%

Revenue / Share (Annual)$29.53

Tangible BV / Share (Annual)$15.82

Forward P/E5.15x

Free OCF CAGR (5Y)-31.95%

Price vs S&P 500 (52W)-60.93%

P/E Ratio (TTM)4.96x

Year-to-Date Return-41.79%

5-Day Price Return-6.98%

EPS Normalized (Annual)$3.18

ROA (5Y Avg)3.08%

Net Profit Margin (Annual)10.79%

Month-to-Date Return-3.28%

Cash Flow / Share (TTM)$2.60

EBITD / Share (Annual)$5.85

EPS Growth (3Y)15.35%

Operating Margin (Annual)16.29%

LT Debt / Equity (Annual)0.25x

P/CF (TTM)3.56x

ROI (5Y Avg)4.31%

P/E Excl Extra (TTM)4.96x

LT Debt / Equity (Quarterly)0.26x

EPS Basic Excl Extra (TTM)$1.09

P/TBV (Quarterly)0.47x

Payout Ratio (Annual)7.39%

P/B Ratio (Annual)0.58x

Dividend / Share (TTM)$0.24

Inventory Turnover (TTM)2.41x

Pretax Margin (TTM)4.45%

Book Value / Share (Annual)$16.71

Price vs S&P 500 (13W)-41.36%

Net Margin Growth (5Y)7.81%

Dividend Yield (TTM)4.33%

Beta0.98x

P/FCF (Annual)5.88x

Revenue / Share (TTM)$29.16

ROE (TTM)6.84%

52-Week Low$5.52

vGradeA

gGradeF

mGradeD

vgmGradeC

Show chart for

Earnings Surprise History

Q1 260.14est. 0.15

Analyst Recommendations

Mar 2025

Apr 2025

May 2025

Jun 2025

2.33

2.25

Industry Peers — Drug Wholesale(9)

Symbol	Value Score	Growth Score	Momentum Score	Price
NUSNuSkin Enterprises, Inc.	A	F	D	$5.28
MCKMcKesson Corporation	D	B	C	$739.53
CORCencora, Inc.	D	B	D	$263.64
CAHCardinal Health, Inc.	C	C	C	$195.85
HLFHerbalife Ltd.	B	D	C	$11.39
COSMCosmos Holdings Inc. Common Stock	D	B	D	$0.25
ZSTKZeroStack Corp. Common Stock	—	F	D	$4.90
WGRXWellgistics Health, Inc. Common Stock	D	F	F	$4.39
HWHHWH International Inc. Common Stock	F	F	D	$1.02
HKPDCellyan Biotechnology Co., Ltd Class A Ordinary Shares	—	F	D	$0.52

About

Nu Skin Enterprises develops and distributes beauty and wellness products globally through its Nu Skin brand and Rhyz subsidiary. The company operates across multiple geographic markets, with the Americas segment generating the majority of revenue, particularly from wellness products. Rhyz manages the company's manufacturing operations and strategic investments.